 |
 |

Oncogene Amplification in Squamous Cell Carcinoma of the Head and Neck
W. Davis Merritt, MD;
Mark C. Weissler, MD;
Bartel F. Turk;
Tona M. Gilmer, PhD
Arch Otolaryngol Head Neck Surg. 1990;116(12):1394-1398.
Abstract
 |  |
Cellular oncogenes appear to be involved in the control of normal cell growth and differentiation. The abnormal activation of these genes in naturally occurring and experimentally induced cancers may have an important role in the expression of the malignant phenotype in cancer cells. Mechanisms for the activation of these genes include chromosomal translocation, point mutation, and DNA amplification. The amplification of specific oncogenes correlates with clinical prognosis in several human malignancies, including breast cancer and neuroblastoma. We examined 21 fresh-frozen human squamous cell carcinomas of the aerodigestive tract for amplification of 10 known cellular oncogenes (c-myc, N-myc, L-myc, N-ras, H-ras, K-ras, erb-B, erb-B2, raf, and int-2), using Southern blotting techniques. Eleven of 21 tumors demonstrated a twofold to 11-fold amplification of the int-2 oncogene, one member of a family of genes related to basic fibroblast growth factor. Amplification of c-myc, a gene that codes for a DNA-binding protein involved in the regulation of cell growth, was seen in two tumors. None of the other eight genes studied were amplified in any of the tumor specimens.
(Arch Otolaryngol Head Neck Surg. 1990;116:1394-1398)
Author Affiliations
From the Division of Otolaryngology-Head and Neck Surgery, University of North Carolina at Chapel Hill (Drs Merritt and Weissler); Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, and Department of Chemotherapy, Glaxo Research Laboratories, Research Triangle Park, NC (Mr Turk and Dr Gilmer).
Footnotes
Accepted for publication July 31, 1990.
Presented at the 1989 Meeting of the American Society for Head and Neck Surgery, San Francisco, Calif, April 6, 1989.
Reprint requests to Department of Chemotherapy, V176, Glaxo Research Laboratories, 5 Moore Dr, Research Triangle Park, NC 27709 (Dr Gilmer).
CiteULike Connotea Del.icio.us Digg Reddit Technorati
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Nuclear Matrix Proteins as Malignant Markers in Squamous Cell Carcinoma of the Head and Neck
McCaffery et al.
Arch Otolaryngol Head Neck Surg 1997;123:283-288.
ABSTRACT
MYC Amplification in Squamous Cell Carcinomas of the Head and Neck
Rodrigo et al.
Arch Otolaryngol Head Neck Surg 1996;122:504-507.
ABSTRACT
Molecular Biology of Human Oral Cancer
Wong et al.
CROBM 1996;7:319-328.
ABSTRACT
| FULL TEXT
Chromosome 11q13 Amplification in Head and Neck Squamous Cell Carcinoma: Association With Poor Prognosis
Meredith et al.
Arch Otolaryngol Head Neck Surg 1995;121:790-794.
ABSTRACT
Immunohistochemical Detection of c-myc Protein in Head and Neck Tumors
Gapany et al.
Arch Otolaryngol Head Neck Surg 1994;120:255-259.
ABSTRACT
Chromosome 11Q13 Amplification in Head and Neck Squamous Cell Carcinoma
Williams et al.
Arch Otolaryngol Head Neck Surg 1993;119:1238-1243.
ABSTRACT
Expression of the Double-Stranded RNA-Dependent Protein Kinase (p68) in Squamous Cell Carcinoma of the Head and Neck Region
Haines et al.
Arch Otolaryngol Head Neck Surg 1993;119:1142-1147.
ABSTRACT
Genetics of Tumors of the Head and Neck
Knudson
Arch Otolaryngol Head Neck Surg 1993;119:735-737.
ABSTRACT
|